|

MHB036C for Injection Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Minghui Pharmaceutical (Hangzhou) Ltd2

Indications

  • Cancer2
  • Advanced Lung Cancer1
  • Advanced Malignant Solid Tumor1
  • Advanced Breast Cancer1
  • Lung Cancer1

Other2 trials

A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
Phase 1/2
A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.